The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 969-975 , October 2003

Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation

Read at the Eighty-third Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 4-7, 2003.

  • Robert Saeid Farivar, MD, PhD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Mass, USA
    • Dr Farivar is a recipient of an individual National Research Service Award (F32-HL6753902) from the National Institutes of Health.
    • ,
  • Lawrence H. Cohn, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Mass, USA
    • Corresponding Author InformationAddress for reprints: Lawrence H. Cohn, MD, Division of Cardiac Surgery, Brigham & Women's Hospital, 75 Francis St, Boston, MA 02115, USA

Received 13 March 2003 ,Revised 14 April 2003 ,Accepted 21 April 2003.

  • Image Result

    Plot of mean serum cholesterol levels in the group of patients whose valves remained intact (control group) versus those undergoing reoperation (explanted). Groups were matched for age of patient at i

    Plot of mean serum cholesterol levels in the group of patients whose valves remained intact (control group) versus those undergoing reoperation (explanted). Groups were matched for age of patient at implantation, sex, and duration of valve survival.

PII: S0022-5223(03)00708-6

doi: 10.1016/S0022-5223(03)00708-6

The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 969-975 , October 2003

Article Tools

* Image Usage & Resolution